Optimer Pharmaceuticals, Inc. (OPTR) Posts Q2 EPS Loss of $0.52
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Consolidated net income (loss): -26.87M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Consolidated net income (loss): -26.87M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) reported Q2 EPS of ($0.52), $0.13 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $33.29 thousand versus the consensus estimate of $260 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
